Unlock instant, AI-driven research and patent intelligence for your innovation.

Treatment of Migraine Headaches with Presynaptic Neurotoxin

a neurotoxin and migraine technology, applied in the field of migraine headache treatment, to achieve the effect of reducing doses, reducing side effects of botulinum toxin, and reducing side effects

Inactive Publication Date: 2015-08-20
MIOTOX LLC
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent describes a way to treat migraines with a therapeutic neurotoxin called Botulinum toxin. The invention involves injecting the toxin into specific areas of the brain called the trigemino-cervical nerves, which are associated with migraines. The invention focuses the toxin injection on the sites of greatest benefit to minimize side effects and increase efficacy. The method also involves adjusting the concentration and volume of the toxin to optimize diffusion and reduce the risk of muscle paralysis. Overall, this approach offers an effective treatment for migraines with reduced side effects and improved results.

Problems solved by technology

Botulinum toxin side effects are usually due to local diffusion to surrounding muscles producing unwanted weakness.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treatment of Migraine Headaches with Presynaptic Neurotoxin
  • Treatment of Migraine Headaches with Presynaptic Neurotoxin

Examples

Experimental program
Comparison scheme
Effect test

case 4

[0099]28-year old woman is involved in a motor vehicle accident with blunt head trauma that results in an acute left epidural hematoma. She undergoes urgent craniotomy. The hematoma is evacuated via a left prieto-temporal craniotomy. She gradually recovers but her course is complicated by ongoing headaches overt the left hemicranium. These are throbbing in nature, interfere with her activities, and associated with nausea and vomiting. These headaches are present on a near daily basis. She is successfully treated with onabotulinumtoxinA in accordance with the injection methodology as outlined in case 1 above.

Aspect 2.

Case 1

[0100]43-year old woman, with a long standing history of migraine, suffers with headache on twenty (20) days out of each month and requires triptan medication on twelve (12) days out of each month to try and control her more disabling headaches. She meets criteria for chronic migraine complicated by medication overuse headache. She fails to respond to numerous prev...

case 3

[0113]64-year old bald man has a long history of migraines dating back to his teens. He now presents with headaches mainly involving the vertex of the head. These occur about 8 days a month. They are disabling, worsened by head movement and associated with sensitivity to light and noise. These are diagnosed as episodic migraine. His neurological examination and brain imaging studies are normal for age. The only exception is that he has senile ptosis.

[0114]Treatment options are reviewed with the patient. He wants to try a preventive approach to avoid getting these disabling headaches. He wants to try onabotulinumtoxinA. However, injections of the frontalis are contra-indicated as these will worsen the senile brow ptosis and in addition the headaches are only located over the vertex of the head.

[0115]OnabotulinumtoxinA is successfully used to treat his headaches using the method described in this invention.

[0116]100 units of onabotulinumtoxinA is diluted in 10 cc of normal saline. The...

case 1

ne Associated Vertigo

[0135]A 54 year old man presented with a long history of vertigo. The onset of vertigo began with minor episodes while the patient was in college. It then presented acutely with an incapacitating episode. The following year, the vertigo then recurred periodically. The patient then had an episode that lasted for 1 month with both symptoms of spinning and imbalance. The patient was worked up diagnostically by ear specialists, otologists, neurologists. Allergy testing was negative. Numerous CT and MRI scans and inner ear testing all proved to be normal with no evidence of tumors or vascular lesions. The diagnosis was confirmed by numerous specialists to be migraine associated vertigo or that of possible vascular origin. Treatment included various antihistamines such as diphenhydramine, meclizine hydrochloride, and scopolamine which did not control the symptoms of vertigo.

[0136]During the past 12 months, prior to initial consultation, the vertigo at times became inc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
widthaaaaaaaaaa
concentrationaaaaaaaaaa
stress disorderaaaaaaaaaa
Login to View More

Abstract

The present invention provides a method for treating a patient for migraine headache, including symptoms associated with migraine headache, such as migraine associated vertigo, which comprises administering to the patient a therapeutically effective amount of an invertebrate presynaptic neurotoxin, e.g. Botulinum toxin in a pharmaceutically safe form.

Description

BACKGROUND OF THE INVENTION[0001]1. Field of the Invention[0002]The present invention provides a method for treating migraine headaches and conditions associated therewith.[0003]2. Background of the Art[0004]Botulinum toxins have been used to treat migraine headache. This is well established in the art. By way of example only, see U.S. Pat. Nos. 5,714,468; 5,721,215; 6,458,365; 7,655,244; 7,704,511 and 7,981,433. All of these references are to be incorporated herewith in their entirety. These patents include: Binder; Botulinum toxin injections to the head for migraine, Blumenfeld; Botulinum toxin injections to the sphenopalatine ganglion, nasal approach and vascular approach, suture line technique (these are not foramina or exit points); Aoki; Tension type headache treatment with Botulinum toxin, and Turkel; 31 sites as for the FDA approved protocol for chronic migraine.[0005]OnabotulinumtoxinA has been FDA approved for chronic migraine, and the dose used is 155 to 195 units, with a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/00A61K38/48A61K38/16
CPCA61K38/4893C12Y304/24069A61K38/164A61K38/48A61P25/06A61P29/00A61K9/0019A61K9/0085
Inventor BINDER, WILLIAM J.
Owner MIOTOX LLC